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Abstract
Measures of personality and psychological distress are correlated and exhibit genetic covariance.
We conducted univariate genome-wide SNP (~2.5 million) and gene-based association analyses of
these traits and examined the overlap in results across traits, including a prediction analysis of
mood states using genetic polygenic scores for personality. Measures of neuroticism, extraversion,
and symptoms of anxiety, depression, and general psychological distress were collected in eight
European cohorts (n ranged 546 to 1 338; maximum total n=6 268) whose mean age ranged from
55 to 79 years. Meta-analysis of the cohort results was performed, with follow-up associations of
the top SNPs and genes investigated in independent cohorts (n=527 to 6 032). Suggestive
association (P=8×10−8) of rs1079196 in the FHIT gene was observed with symptoms of anxiety.
Other notable associations (P<6.09×10−6) included SNPs in five genes for neuroticism (LCE3C,
POLR3A, LMAN1L, ULK3, SCAMP2), KIAA0802 for extraversion, and NOS1 for general
psychological distress. An association between symptoms of depression and rs7582472 (near to
MGAT5 and NCKAP5) was replicated in two independent samples, but other replication findings
were less consistent. Gene-based tests identified a significant locus on chromosome 15 (spanning
five genes) associated with neuroticism which replicated (P<0.05) in an independent cohort.
Support for common genetic effects among personality and mood (particularly neuroticism and
depressive symptoms) was found in terms of SNP association overlap and polygenic score
prediction. The variance explained by individual SNPs was very small (up to 1%) confirming that
there are no moderate/large effects of common SNPs on personality and related traits.
Keywords
GWAS; extraversion; neuroticism; anxiety; depression
Introduction
Personality traits are influenced in part by one’s genetic make-up, with around 50% of their
variation being genetic (Bouchard and Loehlin 2001). They are related to health and other
life characteristics, and predict many aspects of psychiatric illness. In particular, neuroticism
is associated with anxiety and depression (Brandes and Bienvenu 2006). Therefore, a better
understanding of the genetic basis of psychiatric disease and more widespread, milder forms
of psychological distress will be gained by studying stable personality traits alongside
psychiatric symptoms. Such symptoms, while state-dependent, surface against a background
of predisposing personality traits, primarily high neuroticism, and, to a lesser extent, low
extraversion. In this study, we measure the effect of single nucleotide polymorphisms
(SNPs) and genes, with an emphasis on shared effects on personality trait and mood state
measures.
Twin studies have confirmed that substantial genetic effects are shared between neuroticism
and both anxiety and depression, and to a lesser extent, extraversion with depression
(Kendler and Myers 2010; Middeldorp et al. 2005). Such findings provided the impetus for
candidate gene studies to investigate pleiotropic gene effects on personality traits and
psychological distress. For example, variants in GAD1 have been associated with
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neuroticism and anxiety/mood disorder measured in the same sample (Hettema et al. 2006).
Genome-wide association studies (GWAS) have not systematically compared results of
personality traits and mood. However, cross-disorder GWAS analysis has proved
informative for uncovering pleiotropic effects on schizophrenia, bipolar disorder and major
depressive disorder (Huang et al. 2010). The finding that genetic risk scores for neuroticism
predicted major depressive disorder in an independent sample (Middeldorp et al. in press) is
relevant to the present study, which hypothesizes that genetic prediction scores for stable
personality traits will be related to mood states.
The largest personality GWAS to date (de Moor et al. 2011) (n=17 375) failed to replicate
associated SNPs from the first GWAS of personality which had shown some of their top
SNPs to be within/near genes putatively involved in psychiatric illness; nor did this study
confirm previously reported associations for neuroticism. Neuroticism is a strong risk factor
for anxiety, but no GWAS of general anxiety has been published yet. Various GWAS for
major depression exist, the largest included 5763 cases and 6901 controls (Wray et al. 2010).
No SNPs exceeded genome-wide significance, but there was some support for ADCY3,
GAL and CAGNA1C genes. Genetic studies based on continuous measures of depressive
symptoms in normal populations have also had some success. A linkage study of the
depression subscale of the Hospital Anxiety and Depression Scale reported a potentially
linked chromosomal region on 11q which their follow-up population-based association
analysis suggested was partly explained by the OPCML or APLP2 genes (Schol-Gelok et al.
2010). The present study is the first GWAS of symptoms of anxiety and depression sampled
from the general population.
The aim of the present study is to compare the results of genome-wide SNP and gene-based
analyses for neuroticism and extraversion personality traits, and symptoms of anxiety,
depression and general psychological distress. These measures were all based on continua,
sampled from population-based cohorts living in Europe. Whereas the cohorts varied in age,
personality is largely stable across the lifetime and these stable effects in later life are
predominantly genetic in origin (Johnson et al. 2005); so, too, are the genetic determinants
of anxiety and depression (Gillespie et al. 2004). It is this stable genetic variance that is of
interest to the present study. Replication cohorts were available from Australia, Germany
and The Netherlands.
Materials and Methods
Sample
CROATIA-Vis & CROATIA-Korcula—Adults living in the Croatian villages of Komiza
and Vis (island of Vis) and from Korcula (island of Korcula) were recruited within a larger
epidemiological study of genetically isolated populations (Rudan et al. 1999). The
CROATIA-Vis study comprised 536 women and 388 men aged 18–93 years
(mean=56.4±15.5). The CROATIA-Korcula study comprised 573 women and 325 men aged
18–98 years (mean=56.3±13.9).
Lothian Birth Cohorts 1921 (LBC1921) and 1936 (LBC1936)—These relatively
healthy older individuals, living in the Lothian region of Scotland, were born in 1921 or
1936 and assessed on psychological and medical traits from the age of 79 (LBC1921) or 70
(LBC1936) years (Luciano et al. 2010). In the LBC1921, genotype and phenotype data were
available for 426 (personality) and 517 (depression, anxiety) participants (58% female);
mean age of ~81 years (range=80–82) when personality was assessed and 79±0.6 years
(range=77–81) when depression and anxiety symptoms were measured. In the LBC1936,
880 (personality) and 1 003 (depression, anxiety) individuals (50% female) had genotype
and phenotype data; mean age of 69.5±0.8 years (range=67–71).
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Orkney Complex Disease Study (ORCADES)—This is a family-based, cross-
sectional study in the isolated Scottish archipelago of Orkney. Genetic diversity in this
population is decreased compared to mainland Scotland (McQuillan et al. 2008). Data from
445 healthy volunteers (57% female) from a subgroup of 10 islands, aged 18–84 years
(mean=54.9±13.8) with known Orcadian ancestry, were available. Personality assessments
were collected during 2005–2007.
Manchester & Newcastle
The University of Manchester Longitudinal Study of Cognition (Rabbitt et al. 2004)
includes individuals from Greater Manchester and Newcastle-upon-Tyne. We focus on first-
test wave data where the sample size was the largest. Manchester participants (n=796) were
41–84 years (mean=64.6±6.2) when assessed on personality, and 41–82 years
(mean=62.8±6.1) when measured for depression. Newcastle participants (n=751) were 51–
86 years (mean=65.8±6.0) when assessed on personality, and 50–84 years (mean=62.7±6.3)
when measured for depression. Women comprised ~71% of the samples.
Nijmegen Biomedical Study
This is a population-based survey conducted by the Radboud University Nijmegen Medical
Centre (Wetzels et al. 2007) in Nijmegen, a town in the eastern part of The Netherlands.
Age- and sex-stratified randomly selected adult inhabitants received an invitation to fill out a
postal questionnaire on lifestyle and medical history. Genotype and phenotype data were
available for 1 338 participants (50.5% female), aged 27–78 years (mean=61.5±10.3).
All studies conformed to the ethical guidelines of the 1975 Declaration of Helsinki and were
approved by appropriate ethics boards with participants signing informed consent prior to
participation.
Measures
CROATIA-Vis & CROATIA-Korcula—Participants completed a translated version
(Ivkovic et al. 2007) of the Eysenck Personality Questionnaire-Revised (short form; EPQ-R)
and the General Health Questionnaire 30 (GHQ). The EPQ-R is a self-report inventory with
each scale tested by 12 items requiring a binary ‘yes/no’ response (Eysenck and Eysenck
1975). The GHQ is a 30-item, self-report questionnaire of recent psychological distress with
4-response categories (Goldberg and Williams 1988).
LBC1921 & LBC1936—Personality was measured by the International Personality Item
Pool Big-Five 50-item inventory (Goldberg 1999), consisting of 10 items for each trait.
Anxiety and depression symptoms were quantified using the Hospital Anxiety Depression
Scale (Zigmond and Snaith 1983), containing seven items each for anxiety and depression,
the total score giving a general measure of psychological distress.
ORCADES—EPQ-R (short form) was used to measure personality.
Manchester & Newcastle—The respective personality and depression scales were the
EPQ and the Beck Depression Inventory (BDI, Beck et al. 1961). The BDI is a 21-question
multiple-choice self-report inventory, in which the severity of each symptom is rated on a 4-
point scale.
Nijmegen Biomedical Study
Neuroticism and extraversion (12 items/scale) were measured using the Dutch version of the
EPQ-R Short Scale (Sanderman et al. 1991). Depressive symptoms were measured using the
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BDI and anxiety symptoms via a Dutch version of the Symptom Checklist 90 (Arrindell and
Ettema 1986), a self report inventory which includes 10 items from the anxiety scale which
are rated on a 5-point scale of symptom distress.
Genotyping and Imputation
DNA was extracted from blood samples. Genotyping of CROATIA-Vis, LBC and English
samples was conducted by the Genetics Core Laboratory at the Wellcome Trust Clinical
Research Facility, Western General Hospital, Scotland. CROATIA-Korcula and ORCADES
genotyping was undertaken by Helmholtz Zentrum München, GmbH, Neuherberg,
Germany, and the Nijmegen Biomedical Study genotyping was performed by deCODE
Genetics, Iceland. For genotype quality control (QC) procedures see Table S1. Standard
checks for gender discrepancies, individual relatedness (in the non-isolate cohorts only), and
non-Caucasian ascent were done—with necessary exclusions made. Population stratification
factors were estimated via multidimensional scaling (MDS) using an identity-by-state
distance matrix; the first three MDS components were covaried for in the association
analysis.
Due to differences in SNP arrays used between cohorts, genomic coverage was extended to
~2.5M common SNPs by imputation using the HapMap phase II CEU data (NCBI build 36
(UCSC hg18)) as the reference sample and MACH software. SNPs with low imputation
quality (r-squared<0.30) were removed.
Statistical Analysis
GWAS analyses of autosomes were conducted in each study using linear regression of
standardised traits adjusted for the effects of sex, age and population stratification. Dosage
analysis accounted for differential imputation quality of SNPs. In the CROATIA-Vis,
CROATIA-Korcula and ORCADES cohorts, analyses were performed using the *ABEL
suite of software (Aulchenko et al. 2007) making adjustments for pedigree structure. For the
other cohorts, association analyses were performed in mach2qtl (Li et al. 2009). A weighted
inverse variance method in METAL (Willer et al. 2010) was used to meta-analyse the
results. A genome-wide significance level of P<5×10−8 (Dudbridge and Gusnanto 2008) and
a suggestive significance level of 6.09×10−6 (Duggal et al. 2008) was adopted.
To further assess pleiotropic SNP effects, prediction analyses were performed in which
polygenic scores for extraversion and neuroticism were used to predict phenotypic variation
in mood measures. Because anxiety, depression and psychological distress symptoms were
available in a subset of cohorts, polygenic scores for personality were estimated from
GWAS meta-analysis results based on cohorts who did not have the mood measure under
investigation. Thus, the prediction cohort was independent of the cohort in which polygenic
scores were based. Polygenic scores were calculated (in PLINK; Purcell et al. 2007) by
summing across all genotyped SNPs, where the number of reference alleles (0, 1 or 2) at that
SNP was multiplied by the effect size of that SNP. Each of the personality polygenic scores
was correlated with each of the mood traits, controlling also for the number of SNPs used in
the scoring. This was done separately for each cohort; a meta-analysis of the correlations
was conducted in META 5.3 (Schwarzer 1989). For the replication cohorts, personality
polygenic scores were estimated from all the Discovery cohorts, with personality predicted
in the Australian cohort and mood states predicted in the German and NTR cohorts.
A gene-based test was performed using VEGAS (Liu et al. 2010). Such tests can be more
powerful than individual level SNP association because weaker signals from multiple causal
variants in a gene will contribute evidence to gene significance whereas in GWAS these
would likely be inseparable from random noise. Meta-analysis SNP P-values were used as
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the input, with the program assigning them to genes, and assessing the combined effect of all
SNPs within a gene while accounting for SNP linkage disequilibrium. Almost 18,000 genes
were tested, annotated to positions on the UCSC Genome Browser (hg18 assembly) which
include regulatory regions located ±50 kb of 5´ and 3´ untranslated regions. Bonferroni
significance was set at P<2.8×10−6 based on a correction for the number of genes tested.
Replication Cohorts
Perszonality—Neuroticism data (n=6 032) were drawn from three Australian cohorts of
twin families measured in 1980, 1989 and 2002 on the EPQ 23- (1980 cohort) or 12-item
scale (1989 and 2002 cohorts) at a mean age of 32.5±11.8 years (62.9% female).
Extraversion data (n=5 443) were available from the 1980 and 1989 cohorts, based on
respective 21- and 12-items of the EPQ; the mean age was 31.6±12 years (64.7% female).
For details on cohort ascertainment and measure reliability see Birley et al. (2006).
Participants were genotyped on an Illumina SNP microarray chip (317K, 370K-array, 370-
Quad, 610-Quad, or humanCNV370-Quadv3) in different genotyping centres with
imputation to ~2.5 million SNPs using Hap Map Phase II data and MACH. QC procedures
were applied separately to each project (Wray et al. 2010). Association analysis included
sex, age, cohort, and the population stratification components as covariates; a variance
components approach accounted for relatedness among individuals in MERLIN (Chen and
Abecasis 2007).
Mood
Germany—Anxiety and depression symptoms (measured by the Profile of Mood States,
McNair et al. 1992) were available in a population cohort aged 52±16 years. General
psychological distress was indexed by a composite score of anxiety and depression. GWAS
data (Illumina HumanHap300 chip) were available for 527 (54% females) participants. For
QC of the GWAS data see Stefannson et al. (2008). A linear regression was performed
including the covariates age, sex and the first three MDS components in PLINK (Purcell et
al. 2007).
Netherlands Twin Register (NTR)—Longitudinal data have been collected since 1991
in twins/their family members registered in the NTR. In 1993 and 1997, depression was
measured with the BDI (Beck et al. 1974). Anxious depression (comparable to
psychological distress) was measured with the (young) Adult Self Report (Achenbach and
Rescorla 2003) in 1991, 1995, 1997, 2000, 2002 and 2009. BDI data comprised the 1997
dataset complemented with 1993 data, and the psychological distress dataset used the 2009
dataset complemented with data from the other time-points. The number of unrelated
individuals (>18 years) with genotype and phenotype data was 2 685 (psychological
distress) and 1 383 (depression). Mean age was 45.1 (SD 14.9) and 37.5 years (SD 12.3).
Genome-wide genotyping was performed in a selection of subjects as part of six projects,
including around 40% of the sample who participated in one of two Major Depressive
Disorder GWAS studies (Sullivan et al. 2009; Wray et al. 2010). Affymetrix 6.0, Affymetrix
Perlegen 5.0, Illumina 370, Illumina 660 and Illumina Omni Express 1M platforms were
used. Following exclusions based on standard QC (see Psychiatric Genetics Network 2009),
data were merged and imputed against the reference set using IMPUTE v2. After
imputation, genotype dosage was calculated if the highest genotype probability was above
90%.
Results
Raw score descriptive statistics for the GWAS cohorts are shown in Table 1. Analyses were
performed on standardised scores for measure compatibility. Correlations among the
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measures within each cohort were significant (Table S2). P-values from meta-analysis are
presented in Manhattan and Q-Q plots (Figures S1 and S2). No SNPs surpassed genome-
wide significance. Effect size statistics and P-values for SNPs reaching suggestive
significance are shown in Table 2. The top 100 SNPs for each measure appear in Table S3;
whereas these do not pass the stringent significance tests of GWAS, they may lie in existing
candidate genes.
For neuroticism, seven independent SNPs in five genes showed suggestive significance.
Four SNPs showed suggestive association with extraversion, with two in the same locus.
Five SNPs were identified for depression symptoms: three located in genes (RAVER1,
WWOX, FAM190A) and two near genes. Three SNPs passed suggestive significance for
anxiety symptoms: two located in FHIT and one nearby ZNF438. For psychological distress
symptoms, four SNPs showed suggestive association: three were near TNFRSF21 and the
other located in NOS1. Nominally significant associations with the other correlated
variables for each of the suggestively associated SNPs are reported in Table 2. Pleiotropic
effects with other variables were indicated for all the top SNPs except those for extraversion.
The extraversion polygenic score significantly predicted psychological distress variation
(r=0.03, P=0.04), and the neuroticism polygenic score significantly predicted depression
symptoms (r=0.03, P=0.03).
Results for the top 10 most significant genes from the gene-based analysis are reported in
Table 3. Significant gene associations at the Bonferroni-corrected significance level were
observed for neuroticism. These associated genes included C15orf17, POLR3A, MPI,
SCAMP2, ULK3, COX5A. With the exception of POLR3A, they were located in a region
on chromosome 15 in very tight LD, so the assignment of the same SNP to multiple genes at
this locus occurred where gene boundaries overlapped. Only one of these genes showed
nominal significance for the other traits: POLR3A was associated with depression symptoms
(P=0.026). The most significant genes for the other traits included: PNMA1 for extraversion
(P=6×10−6), GRAP for depression symptoms (P=1.9×10−5), RTTN for anxiety symptoms
(P=1×10−4), and ARID3A for psychological distress symptoms (P=2.1×10−5). We checked
the gene-based P-value for genes in which suggestively-associated SNPs from the GWAS
were located. For extraversion, the KIAA0802 gene showed a P-value of 0.051. All the
neuroticism top SNPs were in the top 10 gene list, including three genes that were genome-
wide significant. For anxiety symptoms, the FHIT gene was not nominally significant
(P=0.44). For depression symptoms, FAM190A was not tested, but WWOX and RAVER1
showed respective P-values of 0.08 and 0.50. For psychological distress symptoms, NOS1
was nominally significant (P=0.005).
Suggestively associated SNPs from the GWAS meta-analysis were examined in replication
cohorts (Table 4). Four SNPs showed association (two with neuroticism, one with
depressive symptoms, and two with psychological distress symptoms) at a significance level
of 0.05. One of these, rs7582472, was associated with depressive symptoms in German
(P=0.013) and NTR (P=0.006) cohorts, and showed allelic effects in the same direction as
the meta-analysis result. Replication results for the genes associated with neuroticism (Table
3) were nominally significant for the five genes in LD on chromosome 15. Polygenic scores
of personality were significant predictors of trait scores of personality (P<0.05) in the
Australian cohort, but they explained very little variance (0.1%) in extraversion and
neuroticism. In the German cohort, genetic profile scores of extraversion were negatively
correlated with symptoms of anxiety (r=−0.09; P=0.044), depression (r=−0.10; P=0.022) and
psychological distress (r=−0.10; P=0.021). In the NTR cohort, genetic profile scores of
neuroticism predicted psychological distress (r=0.04; P=0.045).
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Discussion
Several SNPs in known genes showed suggestive association with measures of neuroticism,
extraversion, symptoms of anxiety, depression, and general psychological distress. One of
these (rs7582472) was associated with symptoms of depression in two independent cohorts.
One of the top SNPs (and a gene, POLR3A, from the gene-based test) for neuroticism
showed pleiotropic effects for symptoms of depression, whereas for extraversion no such
effects were observed. Genetic profile scores for extraversion predicted mood state
phenotypes in the expected direction in one of the replication cohorts, indicating genetic
overlap between the traits. A gene-based test identified six genes associated with
neuroticism; five were located in a region of high LD on chromosome 15 and replicated in
an independent cohort.
Phenotypic correlations among neuroticism, anxiety and depression symptoms were
substantial; therefore, we expected overlap in the association results. Shared genetic
association effects can represent: correlated type 1 error, true genetic pleiotropy, or direct
effects of a gene on one trait that indirectly influences the other through a causal pathway.
For top neuroticism associations, we observed nominally significant associations with
depressive symptoms for SNPs in the POLR3A gene. For extraversion, none of the top hits
showed nominal significance for any other trait (but this correlated less strongly with the
other measures). The prediction analyses confirmed phenotypic variance in depression/
psychological distress attributed to polygenic neuroticism scores. In line with findings that
showed pleiotropy was characteristic of 17% of genes and 5% of SNPs associated with
diseases/disease traits (Sivakumaran et al. 2011), we interpret our overlapping results across
traits as evidence of genetic pleiotropy; alternatively, indirect genetic effects on the
correlated trait might be operating. It is also possible that they instead reflect shared type 1
error, although the partly non-overlapping nature of the samples across traits (e.g., the
GWAS for depressive symptom scores was a subset of the GWAS sample for neuroticism)
should have the effect of reducing correlated error variance.
Our most significant GWAS finding was for SNPs in FHIT (fragile histidine triad gene
which codes for a protein involved in purine metabolism) influencing anxiety symptoms.
These SNPs were also associated with psychological distress, which taps anxiety,
depression, and social dysfunction. SNPs nearby/in the FHIT gene have been associated
with recurrent early-onset major depressive disorder in a GWAS (Shi et al. 2011).
Importantly, 35% of the cases in their study showed a co-morbid anxiety disorder diagnosis.
Our top FHIT SNPs were not in LD with rs10514718, their associated marker (located
176kb from FHIT). In our study, rs10514718 fell short of association with anxiety; the C
allele conferred a 0.12 SD decrease in scores (P=0.08).
For depressive symptoms, the most interesting genes—MGAT5 (mannosyl (alpha-1,6-)-
glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase) and NCKAP5/NAP5 (Nck-
associated protein 5)—were located 300–400kb 5’ to a SNP replicated in the German and
NTR cohorts. Mgat5 mouse knockouts exhibit lower depression-like behaviours especially
under stress-induced conditions (Soleimani et al. 2008); and a GWAS of bipolar disorder
reported NAP5 as a gene/region worthy of further study (Smith et al. 2009). Our associated
SNP is some distance from these genes and, and in the CEU population, is located in a
recombination hotspot, making it less likely that this variant relates to these genes.
Additionally, gene-based testing did not show significant associations of these two genes
with depression symptoms.
TNFRSF21 (tumor necrosis factor receptor superfamily, member 21) was the closest (~34kb
downstream) gene to eight intergenic SNPs reaching suggestive significance for
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psychological distress. Whereas TNFRSF21 presents as a good candidate gene for anxiety
and depression—due to its role in inflammation and immune regulation—our SNPs were not
in LD with SNPs in TNFRSF21. A SNP located in NOS1 (encoding nitric oxide synthase 1)
was suggestively associated with psychological distress, but unlike the SNPs located near
TNFRSF21, this SNP showed no association with anxiety/depression symptoms. In rodent
models of stress, nitric oxide levels in plasma and brain affect stress-induced
neurobehavioural measures and stress susceptibility (Gilhotr et al. 2010). In humans,
haplotypes in NOS1 have been associated with suicidal behaviour (Rujescu et al. 2008).
The gene-based test identified six genes associated with neuroticism. Five (C15orf17, MPI,
SCAMP2, ULK3, COX5A) were located in a region of tight LD, which was replicated in the
Australian cohort. SNPs in ULK3 and SCAMP2 passed suggestive significance in the
GWAS—and one in SCAMP2 was significant (albeit in the opposite direction) in the
Australian cohort. SCAMP2 (secretory carrier membrane protein 2) was an interesting
candidate because SCAMP2 plays a role in plasmalemmal norepinephrine transporter
function, a drug target of mood disorder (Matthies et al. 2009). While not reaching corrected
significance, NDE1 (nudE nuclear distribution gene E homolog 1) was nominally associated
with symptoms of depression, and has been related to major depression. This gene encodes a
protein involved in microtubal organisation, mitosis and neuronal migration. Variants in
NDE1 affect expression levels of genes targeted by drugs for bipolar disorder and major
depression (Hennah and Porteous 2009). There was good agreement between the top SNP
associations (i.e., those located in genes) and the gene-based tests. That FHIT and RAVER1
were not significant in the gene-based test indicates that the SNP associations within these
genes are possibly type 1 error, are in LD with another important gene, or have very specific
effects on gene functioning, for instance if they are exonic SNPs.
The main limitation of the present study was the relatively small sample size, particularly for
the measurement of anxiety. Using the more conservative alpha level, power calculations for
our varying sample sizes ranged 45%−99% to detect an effect size of 1%. This resulted in
insufficient power to attain genome-wide significance for some associations that were
suggestive. However, it has been shown that most borderline GWAS significant results
(i.e.,P>5×10−8 and P≤10−7) are potentially genuine associations (Panagiotou and Ioannidis
2011). Thus, we can place confidence in several of our SNP and gene-based test findings
because of the replication support we found. The use of different psychological scales across
cohorts is considered advantageous because the meta-analysis results will invariably detect
associations that relate to reliable trait variance (i.e., variance that is common across tests
that purportedly measure the same underlying trait).
In summary, our strongest GWAS finding was for a SNP near MGAT5 and NCKAP5,
which was suggestively associated with depression symptoms and replicated in two cohorts.
Our gene based test identified a locus on chromosome 15 associated with neuroticism, and
this region was also replicated. Single SNP results often generalised across multiple traits,
particularly neuroticism and depression, and by using genetic personality profile scores we
were able to predict (in the hypothesised direction) symptoms of depression from
neuroticism polygenic scores. In the replication cohorts, all mood states were predicted by
extraversion polygenic scores (in the German cohort) and psychological distress from
neuroticism polygenic scores (in the NTR). Future work should encompass multivariate
genetic association analysis of personality traits and mood states because the covariance
among these variables might more reliably index people at greater genetic predisposition to
psychological distress by removing environmental variance affecting mood. Some of our
results have been linked previously to clinical psychiatric traits, suggesting that personality
and mood traits sampled in the general population may be relevant to clinical pathology of
mood.
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